Evotec EVO
$1.32 −$0.13 (-8.97%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $1.34 +1.52%
Open$1.38
Prev close$1.45
Day range$1.32 – $1.38
Volume77.6K
Market cap$469.11M
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026 · reported in EUR
Revenue€164.93M+0.6% YoY
Operating profit-€27.12M+39.2% YoY
Net profit-€26.74M+37.9% YoY
Diluted EPS-€0.08+37.5% YoY
Free cash flow-€51.92M+41.6% YoY
Operating cash flow-€43.91M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin10.3%
Operating margin-17.5%
Net margin-25.2%
Return on equity-25.1%
Return on assets-11.0%
Return on invested capital-14.5%
Current ratio2.32
Liabilities / assets57.4%
Cash & investments€418.48M
Total debt€417.21M
Net cash (debt)€1.27M
Where the revenue comes from
Quarter 2026/Q1
By business line
This company reports in its own local currency, not U.S. dollars. Every figure below is labeled with its real currency, not automatically converted.
Income statement
| Line item | 2026 Q3 (EUR) |
2026 Q2 (EUR) |
2026 Q1 (EUR) |
2025 ANNUAL (EUR) |
2025 Q4 (EUR) |
|---|---|---|---|---|---|
| Total Revenue as Reported | €164.93M | €143.48M | €156.64M | €788.37M | €253.27M |
| Total Operating Revenue | €164.93M | €143.48M | €156.64M | €788.37M | €253.27M |
| Cost of Revenue | €145.13M | €145.06M | €158.21M | €674.15M | €196.17M |
| Gross Profit | €19.80M | -€1.58M | -€1.57M | €114.22M | €57.11M |
| Operating Expense | €46.91M | €87.74M | €44.85M | €170.04M | €19.90M |
| Selling and Admin Expenses | €38.78M | €39.29M | €43.79M | €175.97M | €37.57M |
| Research & Development | €9.34M | €10.26M | €10.08M | €37.51M | -€4.75M |
| Other Operating Expenses | -€1.22M | €38.20M | -€9.02M | -€1.83M | €28.69M |
| Operating Profit | -€27.12M | -€89.32M | -€46.42M | -€55.82M | €37.21M |
| Net Non-Operating Interest Income (Expense) | -€1.20M | -€2.79M | -€790,000.00 | -€10.02M | -€2.60M |
| Non-Operating Interest Income | €2.71M | €183,000.00 | €1.79M | €4.42M | €1.16M |
| Non-Operating Interest Expense | €3.91M | €2.97M | €2.58M | €14.44M | €3.76M |
| Other Income (Expense) | €6.29M | €43.99M | -€74.97M | -€20.93M | -€5.15M |
| Gain on Sale of Security | -€1.57M | €69.84M | €192,000.00 | -€677,000.00 | -€2.42M |
| Earnings from Equity Interest | -€370,000.00 | -€869,000.00 | -€286,000.00 | -€1.09M | -€349,000.00 |
| Special Income (Charges) | €7.00M | -€23.95M | -€74.97M | -€399,000.00 | -€1.14M |
| -Less:Restructuring and Mergern & Acquisition | -€7.00M | €23.95M | €74.97M | €633,000.00 | €1.37M |
| Other Non-Operating Income (Expenses) | €1.23M | -€1.02M | €100,000.00 | -€18.77M | -€1.24M |
| Pretax Profit | -€22.02M | -€48.12M | -€122.18M | -€86.77M | €29.46M |
| Tax | €4.72M | -€1.47M | -€244,000.00 | €16.75M | €14.84M |
| Net Profit | -€26.74M | -€46.65M | -€121.94M | -€103.52M | €14.62M |
| Profit from Continuing Operations | -€26.74M | -€46.65M | -€121.94M | -€103.52M | €14.62M |
| Net Income to Parent Company | -€26.74M | -€46.65M | -€121.94M | -€103.52M | €14.62M |
| Net Income to Common Stockholders | -€26.74M | -€46.65M | -€121.94M | -€103.52M | €14.62M |
| Basic EPS | -€0.08 | -€0.13 | -€0.34 | -€0.29 | €0.05 |
| Diluted EPS | -€0.08 | -€0.13 | -€0.35 | -€0.29 | €0.05 |
| -Selling & Marketing Expense | – | – | – | €17.38M | – |
| -General & Admin Expense | – | – | – | €158.60M | – |
| Other Taxes | – | – | – | -€41.61M | – |
| -Less:Impairment of Capital Assets | – | – | – | €0.00 | – |
| -Less:Other Special Charges | – | – | – | €1.68M | – |
| -Gain on Sale Of Business | – | – | – | €1.91M | – |
Balance sheet
| Line item | 2026 Q3 (EUR) |
2026 Q2 (EUR) |
2026 Q1 (EUR) |
2025 ANNUAL (EUR) |
2025 Q4 (EUR) |
|---|---|---|---|---|---|
| Total Assets | €1.50B | €1.57B | €1.64B | €1.71B | €1.71B |
| Total Current Assets | €663.26M | €728.89M | €711.28M | €762.95M | €762.95M |
| Cash and Cash Equivalents & Short-Term Investments | €418.48M | €483.62M | €463.78M | €463.02M | €463.02M |
| -Cash and Cash Equivalents | €299.01M | €348.36M | €387.91M | €401.79M | €401.79M |
| -Short Term Investments | €119.47M | €135.26M | €75.87M | €61.23M | €61.23M |
| Receivables | €171.27M | €166.46M | €167.05M | €213.51M | €213.51M |
| -Accounts Receivable | €108.56M | €96.35M | €98.26M | €135.96M | €135.96M |
| -Taxes Receivable | €34.03M | €36.82M | €33.47M | €49.25M | €49.25M |
| -Other Receivables | €28.68M | €33.29M | €35.32M | €28.30M | €28.30M |
| Inventory | €37.71M | €38.56M | €32.98M | €29.32M | €29.32M |
| Other Current Assets | €35.80M | €40.25M | €43.55M | €709,000.00 | €709,000.00 |
| Total Non-Current Assets | €841.71M | €845.09M | €928.53M | €951.00M | €951.00M |
| Net PPE | €444.54M | €449.77M | €530.84M | €554.63M | €554.63M |
| Investments and Advances | €39.21M | €42.55M | €53.31M | €52.63M | €52.63M |
| -Available for Sale Securities | €36.11M | €39.07M | €48.97M | €48.00M | €48.00M |
| -Long Term Equity Investment | €3.11M | €3.48M | €4.35M | €4.63M | €4.63M |
| Non Current Accounts Receivables | €49.25M | €43.27M | €36.87M | €36.35M | €36.35M |
| Goodwill and Other Intangible Assets | €307.23M | €306.51M | €305.41M | €303.94M | €303.94M |
| Non-Current Deferred Assets | €113,000.00 | €1.89M | €1.69M | €2.95M | €2.95M |
| Other Non-Current Assets | €1.36M | €1.10M | €417,000.00 | €508,000.00 | €508,000.00 |
| Total Liabilities | €863.31M | €908.40M | €940.19M | €900.24M | €900.24M |
| Total Current Liabilities | €285.64M | €312.46M | €423.37M | €368.07M | €368.07M |
| Payables | €57.29M | €58.03M | €64.42M | €81.03M | €81.03M |
| -Accounts Payable | €48.58M | €49.13M | €54.90M | €64.76M | €64.76M |
| -Total Tax Payable | €8.71M | €8.90M | €9.52M | €16.27M | €16.27M |
| Short-Term Debt and Capital Lease Obligation | €64.61M | €61.54M | €88.62M | €103.68M | €103.68M |
| Current Provisions | €74.26M | €92.76M | €130.83M | €58.54M | €58.54M |
| Current Deferred Liabilities | €64.08M | €72.53M | €114.69M | €108.07M | €108.07M |
| Other Current Liabilities | €25.41M | €27.60M | €24.83M | €11.10M | €11.10M |
| Total Non-Current Liabilities | €577.67M | €595.94M | €516.82M | €532.17M | €532.17M |
| Long Term Debt and Capital Lease Obligation | €417.21M | €414.32M | €298.85M | €344.01M | €344.01M |
| Non-Current Liabilities | €27.38M | €26.23M | €64.17M | €18.04M | €18.04M |
| Non-Current Deferred Liabilities | €133.08M | €154.05M | €152.46M | €168.41M | €168.41M |
| Other Non-Current Liabilities | -€1,000.00 | €1.34M | €1.34M | €1.72M | €1.72M |
| Total Equity | €641.66M | €665.58M | €699.62M | €813.70M | €813.70M |
| Stockholders' Equity | €641.66M | €665.58M | €699.62M | €813.70M | €813.70M |
| Capital Stock | €177.91M | €177.91M | €177.88M | €177.78M | €177.78M |
| -Common Stock | €177.91M | €177.91M | €177.88M | €177.78M | €177.78M |
| Additional Paid-In Capital | €1.47B | €1.47B | €1.46B | €1.46B | €1.46B |
| Retained Earnings | -€971.22M | -€944.47M | -€897.82M | -€775.89M | -€775.89M |
| Less: Treasury Stock | -€531,000.00 | -€980,000.00 | -€1.14M | -€1.55M | -€1.55M |
| Gains/Losses Not Affecting Retained Earnings | -€35.18M | -€35.77M | -€38.32M | -€45.11M | -€45.11M |
| Other Equity Interests | -€1,000.00 | -€1,000.00 | – | – | – |
| -Long Term Debt | – | €414.32M | €298.85M | €344.01M | €344.01M |
| Prepaid Assets | – | – | – | €18.97M | €18.97M |
| Restricted Cash | – | – | – | €33.59M | €33.59M |
| -Gross PPE | – | – | – | €1.07B | €1.07B |
| -Accumulated Depreciation | – | – | – | -€519.54M | -€519.54M |
| -Goodwill | – | – | – | €272.37M | €272.37M |
| -Other Intangible Assets | – | – | – | €31.57M | €31.57M |
| -Current Debt | – | – | – | €81.50M | €81.50M |
| -Current Capital Lease Obligation | – | – | – | €22.18M | €22.18M |
Cash flow
| Line item | 2026 Q3 (EUR) |
2026 Q2 (EUR) |
2026 Q1 (EUR) |
2025 ANNUAL (EUR) |
2025 Q4 (EUR) |
|---|---|---|---|---|---|
| Operating Cash Flow | -€43.91M | -€107.19M | -€3.92M | -€9.18M | €63.63M |
| Net cash flow from continuing operations | -€43.91M | -€107.19M | -€3.92M | -€9.18M | €63.63M |
| Net Income from Continuing Operations | -€26.74M | -€46.65M | -€121.94M | -€103.52M | €14.62M |
| Other Non-Cash Items | €37.81M | €22.88M | €46.53M | €28.99M | -€83.42M |
| Change in Working Capital | -€54.98M | -€83.42M | €71.49M | -€60.80M | €6.27M |
| Net cash flow from investing | €7.73M | €19.52M | -€12.43M | €171.59M | €222.38M |
| Net Cash Flow from Continuing Investing Activities | €7.72M | €19.52M | -€12.44M | €171.59M | €222.38M |
| Net PPE Purchase and Sale | -€5.94M | -€9.11M | -€4.08M | -€72.33M | -€14.51M |
| Net Intangibles Purchase and Sale | -€2.13M | -€1.90M | -€6.63M | -€10.08M | -€824,000.00 |
| Net Business Purchase and Sale | €89.39M | -€2.27M | -€4.50M | €216.86M | €231.38M |
| Net Investment Purchase and Sale | -€75.42M | €30.52M | €905,000.00 | €31.97M | €5.48M |
| Net Other Investing Changes | €2,000.00 | -€2,000.00 | €1,000.00 | €1,000.00 | – |
| Financing Cash Flow | -€10.75M | €52.86M | -€19.09M | -€37.63M | -€46.23M |
| Net Cash Flow from Continuing Financing Activities | -€10.75M | €52.86M | -€19.09M | -€37.63M | -€46.23M |
| Net Issuance Payments Of Debt | -€10.64M | €55.75M | -€19.09M | -€29.42M | -€42.44M |
| Cash Dividends Paid | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 |
| Proceeds from Stock Option Exercised | €0.00 | €32,000.00 | €99,000.00 | €225,000.00 | €7,000.00 |
| Ending Cash Balance | €299.01M | €348.36M | €387.91M | €418.52M | €418.52M |
| Net Change in Cash | -€46.94M | -€34.81M | -€35.44M | €124.78M | €239.78M |
| Beginning Cash Balance | €348.36M | €387.91M | €418.52M | €306.39M | €179.27M |
| Effect of Exchange Rate Changes | -€2.41M | -€4.75M | €4.84M | -€12.65M | -€539,000.00 |
| Free Cash Flow | -€51.92M | -€118.20M | -€14.70M | -€91.80M | €48.11M |
| Net Other Financing Charges | – | – | -€1,000.00 | -€1.46M | -€99,000.00 |
| Gain/Loss from Continuing Operations | – | – | – | -€7.29M | – |
| Depreciation & Depletion & Amortization | – | – | – | €99.48M | – |
| Deferred Tax | – | – | – | €16.75M | – |
| -Change in Receivables | – | – | – | -€28.73M | – |
| -Change in Inventory | – | – | – | -€9.56M | – |
| -Change in Payables and Accrued Expense | – | – | – | -€7.30M | – |
| -Change In Other Working Capital | – | – | – | -€15.21M | – |
| Net Common Stock Issuance | – | – | – | -€1.55M | – |
No comments yet — be the first to weigh in on EVO.
Sign in to join the discussion.